The offspring of epileptic mother

1996 ◽  
Vol 63 (4) ◽  
pp. 523-531 ◽  
Author(s):  
S. K. Tamer ◽  
S. Misra ◽  
S. Jaiswal
Keyword(s):  
Epileptic Mother

Case 44: Neural Tube Defect in Infant of Epileptic Mother

2018 ◽  
pp. 305-308
Author(s):  
Douglas Moeckel ◽  
D. Kathy Grange ◽  
Jennifer A. Wambach
Keyword(s):  
Neural Tube ◽  
Neural Tube Defect ◽  
Epileptic Mother

The Epileptic Mother and Her Child

Epilepsia ◽  
1982 ◽  
Vol 23 (1) ◽  
pp. 85-99 ◽  
Author(s):  
Anette Philbert ◽  
Mogens Dam
Keyword(s):  
Epileptic Mother

TRANSPLACENTAL VITAMIN K PREVENTS HAEMORRHAGIC DISEASE OF INFANT OF EPILEPTIC MOTHER

The Lancet ◽  
1982 ◽  
Vol 319 (8283) ◽  
pp. 1247 ◽  
Author(s):  
M.F. Deblay ◽  
P. Vert ◽  
M. Andre ◽  
F. Marchal
Keyword(s):  
Vitamin K ◽  
Epileptic Mother ◽  
Haemorrhagic Disease

Epileptic Mother

1981 ◽  
Vol 38 (4) ◽  
pp. 263-264 ◽  
Author(s):  
J. F. Bale ◽  
R. W. Allen ◽  
J. Hulme ◽  
M. L. Wyman
Keyword(s):  
Epileptic Mother

scholarly journals Fetal Hydantoin Syndrome: A Case Report

1970 ◽  
Vol 30 (1) ◽  
pp. 57-59
Author(s):  
Needa Shrestha Shakya ◽  
Simmi Misra Gurubacharya ◽  
Dhana Raj Aryal
Keyword(s):  
Congenital Anomalies ◽  
Reproductive Age ◽  
Potential Hazard ◽  
Craniofacial Anomalies ◽  
Paediatric Society ◽  
Multiple Congenital Anomalies ◽  
Medical Practitioners ◽  
Growth Deficiency ◽  
Epileptic Mother ◽  
Term Baby

A term baby born to an epileptic mother who was treated with Phenytoin until 10weeks of pregnancy was born with multiple congenital anomalies and diagnosed to have Fetal Hydantoin Syndrome. Infants of mothers who have taken hydantoin during pregnancy have been found to have broad multisystem patterns of abnormalities, including mental retardation, craniofacial anomalies, nail and digital hypoplasia and prenatal onset of growth deficiency. The discussion aims to bring to attention the potential hazard of the use of hydantoin drug during reproductive age to all medical practitioners. Key words: Congenital anomalies, epilepsy, fetal hydantoin syndrome, phenytoin. DOI: 10.3126/jnps.v30i1.2463 Journal of Nepal Paediatric Society Vol.30(1) 2010 57-59

Neonatal Cholestatic Hepatitis from Carbamazepine Exposure during Pregnancy and Breast Feeding

2002 ◽  
Vol 36 (4) ◽  
pp. 644-647 ◽  
Author(s):  
Bernhard Frey ◽  
Christian P Braegger ◽  
Daniela Ghelfi
Keyword(s):  
Breast Feeding ◽  
Liver Dysfunction ◽  
Product Information ◽  
Case Reports ◽  
Diagnostic Procedures ◽  
Cholestatic Hepatitis ◽  
Case Summary ◽  
Epileptic Mother ◽  
Exposure During Pregnancy ◽  
Second Period

OBJECTIVE: To report a case of transient cholestatic hepatitis occurring in an infant between the third and seventh weeks of life, most likely due to carbamazepine exposure during pregnancy and breast feeding. CASE SUMMARY: A boy, born to an epileptic mother who had been treated with carbamazepine monotherapy throughout pregnancy and breast feeding, experienced asphyxia at birth with transient hepatic dysfunction in the first week of life. After full recovery from asphyxia, he experienced a second period of liver dysfunction, presenting as cholestatic hepatitis that lasted approximately 5 weeks. Infectious and metabolic etiologies as well as extrahepatic biliary atresia were excluded. DISCUSSION: Carbamazepine is known to induce hepatic damage in children and adults. As the drug crosses the placenta and is excreted into breast milk, infants of mothers taking carbamazepine might also develop liver dysfunction. In addition to the present case, there are 2 well-documented case reports of cholestasis in association with transplacental and transmammary carbamazepine exposure. CONCLUSIONS: Carbamazepine-induced hepatitis may occur in association with prenatal exposure and breast feeding. This may expose infants to unnecessary diagnostic procedures, and should therefore be mentioned in the company's product information.

scholarly journals A case with multiple abnormalities born to epileptic mother taking anticonvulsant drugs. Anticonvulsant embryopathy.

1991 ◽  
Vol 37 (2) ◽  
pp. 413-418
Author(s):  
Yutaka IMAI ◽  
Yukihiro YOKOKURA ◽  
Tomoaki NAGASHIMA ◽  
Masanari TOYOHASHI ◽  
Yoshimasa SUZUKI ◽  
...  
Keyword(s):  
Anticonvulsant Drugs ◽  
Epileptic Mother ◽  
Multiple Abnormalities
Sign in / Sign up

Export Citation Format

Share Document